Showing results (91-100 of 681) with videos related to
Sort By:
Pageof 69
Journal of Virology|April 30, 2003
Reverse genetics for crimean-congo hemorrhagic fever virusRamon Flick, Kirsten Flick, Heinz Feldmann, et al.Journal of Visualized Experiments : Jove|October 7, 2014
Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomesThomas Hoenen, Ari Watt, Anita Mora, et al.Future Virology|November 3, 2011
Clinical aspects of Marburg hemorrhagic feverMasfique Mehedi, Allison Groseth, Heinz Feldmann, et al.The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.Genome Medicine|February 26, 2011
Tackling Ebola: new insights into prophylactic and therapeutic intervention strategiesEmmie de Wit, Heinz Feldmann, Vincent J MunsterVirus Research|August 23, 2002
Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United StatesAllison Groseth, Ute Ströher, Steven Theriault, et al.The Journal of Infectious Diseases|December 6, 2007
Blockage of filoviral glycoprotein processing by use of a protein-based inhibitorUte Ströher, Laura Willihnganz, François Jean, et al.Trends in Molecular Medicine|April 18, 2006
Ebola virus: unravelling pathogenesis to combat a deadly diseaseThomas Hoenen, Allison Groseth, Darryl Falzarano, et al.Plos Pathogens|September 16, 2021
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathwayWakako Furuyama, Kyle Shifflett, Heinz Feldmann, et al.Nature Medicine|June 7, 2005
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesSteven M Jones, Heinz Feldmann, Ute Ströher, et al.Pageof 69